US Cannabis Stocks Boosted by Milestone Research Law

Dec.07.2022
US Cannabis Stocks Boosted by Milestone Research Law
US bill expands marijuana research, boosting cannabis stocks. It makes it easier for scientists to study the plant.

Following the signing of a landmark bill by US President Joe Biden, cannabis stocks received a boost on Friday as the bill expands marijuana research.


The bipartisan Medical Marijuana and Cannabinoid Research Expansion Act has made it easier for scientists to study this plant by streamlining the application process for approving cannabis-related scientific research and allowing researchers to grow or import marijuana for medical research purposes.


This directs the Department of Health and Human Services (DHHS) to investigate policies prohibiting research on marijuana and provide recommendations on how to eliminate these barriers. It also directs DHHS to research the therapeutic potential of marijuana.


This occurred after President Biden requested a review of the status of marijuana as a Schedule I substance under the Controlled Substances Act in October. It has been reported that the Secure and Fair Enforcement (SAFE) Banking Act will protect banks and other financial institutions from being penalized for providing services to legally-operating cannabis-related businesses, and may be passed by the end of the year.


On Monday morning, US cannabis stocks experienced a surge in response to news updates. Australis Capital Inc (CSE:AUSA, OTCQB:AUSAF) saw a rise of 15%, Planet 13 Holdings Inc (CSE:PLTH, OTCQX:PLNHF) increased by 5.6%, Jushi Holdings Inc (CSE:JUSH, OTCQX:JUSHF) rose by 6.8%, Delta 9 Cannabis Inc (TSX:DN) went up by 4.2%, and FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) saw a 2.8% rise.


The stocks of Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc rose by 2%, Avikana Inc (TSX:AVCN, OTCQX:AVCNF) by 2.7%, Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) by 4%, and Nextleaf Solutions Ltd (CSE:OILS, OTCQB:OILFF) by 0.8%.


2FIRSTS will continue to track and report on this topic, with future updates available on the '2FIRSTSAPP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Lawmakers Push to Include E-Cigarettes in Vietnam’s Revised Investment Law Ban
Lawmakers Push to Include E-Cigarettes in Vietnam’s Revised Investment Law Ban
Vietnam’s National Assembly has debated amendments to the Investment Law that would include e-cigarettes, heated tobacco, and nitrous oxide (N₂O) in the list of prohibited business activities. Lawmakers supported a total ban consistent with WHO recommendations and previous National Assembly resolutions, citing rising youth addiction rates. Finance Minister Nguyễn Văn Thắng confirmed that the ban would apply comprehensively, with a short transition period for foreign factories.
Nov.27 by 2FIRSTS.ai
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco (JT) announced that Ploom AURA has added a second limited-edition colorway, “Bronze Royal,” which will be available in limited quantities through official channels starting November 11, priced at approximately $27.3.
Nov.12 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
Mongolia Proposes Full Regulation of E-Cigarettes Under Tobacco Law
Mongolia Proposes Full Regulation of E-Cigarettes Under Tobacco Law
Mongolia’s Parliament has begun reviewing major amendments to the Tobacco Control Law, which would bring e-cigarettes and other new nicotine products under the same legal framework as traditional cigarettes. The bill also proposes a gradual increase in tobacco excise taxes through 2030 and new restrictions on flavors, marketing, and public smoking.
Nov.26 by 2FIRSTS.ai
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai